NO20006091L - Humant protein C-polypeptid - Google Patents
Humant protein C-polypeptidInfo
- Publication number
- NO20006091L NO20006091L NO20006091A NO20006091A NO20006091L NO 20006091 L NO20006091 L NO 20006091L NO 20006091 A NO20006091 A NO 20006091A NO 20006091 A NO20006091 A NO 20006091A NO 20006091 L NO20006091 L NO 20006091L
- Authority
- NO
- Norway
- Prior art keywords
- polypeptide
- human protein
- isolated
- disorders
- predispose
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6464—Protein C (3.4.21.69)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21069—Protein C activated (3.4.21.69)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- Diabetes (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Cardiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8758598P | 1998-06-01 | 1998-06-01 | |
| PCT/US1999/011969 WO1999063070A1 (en) | 1998-06-01 | 1999-06-01 | Human protein c polypeptide |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20006091D0 NO20006091D0 (no) | 2000-11-30 |
| NO20006091L true NO20006091L (no) | 2001-01-31 |
Family
ID=22206075
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20006091A NO20006091L (no) | 1998-06-01 | 2000-11-30 | Humant protein C-polypeptid |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US20040038288A1 (ja) |
| EP (1) | EP1084235A4 (ja) |
| JP (1) | JP2002517191A (ja) |
| KR (1) | KR20010043941A (ja) |
| CN (1) | CN1303428A (ja) |
| AR (1) | AR020082A1 (ja) |
| AU (1) | AU4409399A (ja) |
| BR (1) | BR9910858A (ja) |
| CA (1) | CA2330171A1 (ja) |
| CO (1) | CO5070672A1 (ja) |
| DZ (1) | DZ2803A1 (ja) |
| EA (1) | EA200001254A1 (ja) |
| HR (1) | HRP20000826A2 (ja) |
| HU (1) | HUP0102014A3 (ja) |
| ID (1) | ID27282A (ja) |
| IL (1) | IL139595A0 (ja) |
| NO (1) | NO20006091L (ja) |
| NZ (1) | NZ507982A (ja) |
| PE (1) | PE20000561A1 (ja) |
| PL (1) | PL344349A1 (ja) |
| SK (1) | SK17502000A3 (ja) |
| SV (1) | SV1999000067A (ja) |
| TR (1) | TR200003552T2 (ja) |
| WO (1) | WO1999063070A1 (ja) |
| ZA (1) | ZA200006647B (ja) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006025995A2 (en) * | 2004-07-27 | 2006-03-09 | The Regents Of The University Of California | Compositions and methods using md-2 mutants and chimeric proteins |
| CN108159399B (zh) * | 2017-12-29 | 2020-07-24 | 华中科技大学同济医学院附属同济医院 | 一种凝血蛋白酶aPC在防治糖尿病心肌病药物中的应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2728240B2 (ja) * | 1988-07-26 | 1998-03-18 | ヘキスト薬品工業株式会社 | ヒトプロテインｃ変異体及びその製造方法 |
| WO1991009960A1 (en) * | 1989-12-29 | 1991-07-11 | Zymogenetics, Inc. | Hybrid protein c |
| WO1991012320A1 (en) * | 1990-02-09 | 1991-08-22 | Zymogenetics, Inc. | Activated protein c with truncated light chain |
| JPH0564588A (ja) * | 1991-08-14 | 1993-03-19 | Teijin Ltd | 短い重鎖を有するヒトプロテインｃおよび活性化ヒトプロテインｃ |
-
1999
- 1999-05-28 SV SV1999000067A patent/SV1999000067A/es not_active Application Discontinuation
- 1999-05-31 AR ARP990102575A patent/AR020082A1/es not_active Application Discontinuation
- 1999-06-01 NZ NZ507982A patent/NZ507982A/en not_active Application Discontinuation
- 1999-06-01 EP EP99927111A patent/EP1084235A4/en not_active Withdrawn
- 1999-06-01 CO CO99034013A patent/CO5070672A1/es unknown
- 1999-06-01 AU AU44093/99A patent/AU4409399A/en not_active Abandoned
- 1999-06-01 KR KR1020007013511A patent/KR20010043941A/ko not_active Application Discontinuation
- 1999-06-01 CN CN99806859A patent/CN1303428A/zh active Pending
- 1999-06-01 PL PL99344349A patent/PL344349A1/xx not_active Application Discontinuation
- 1999-06-01 JP JP2000552266A patent/JP2002517191A/ja not_active Withdrawn
- 1999-06-01 DZ DZ990103A patent/DZ2803A1/xx active
- 1999-06-01 CA CA002330171A patent/CA2330171A1/en not_active Abandoned
- 1999-06-01 PE PE1999000461A patent/PE20000561A1/es not_active Application Discontinuation
- 1999-06-01 TR TR2000/03552T patent/TR200003552T2/xx unknown
- 1999-06-01 WO PCT/US1999/011969 patent/WO1999063070A1/en not_active Application Discontinuation
- 1999-06-01 BR BR9910858-5A patent/BR9910858A/pt not_active IP Right Cessation
- 1999-06-01 SK SK1750-2000A patent/SK17502000A3/sk unknown
- 1999-06-01 HU HU0102014A patent/HUP0102014A3/hu unknown
- 1999-06-01 EA EA200001254A patent/EA200001254A1/ru unknown
- 1999-06-01 ID IDW20002430A patent/ID27282A/id unknown
- 1999-06-01 IL IL13959599A patent/IL139595A0/xx unknown
-
2000
- 2000-11-15 ZA ZA200006647A patent/ZA200006647B/en unknown
- 2000-11-30 NO NO20006091A patent/NO20006091L/no not_active Application Discontinuation
- 2000-11-30 HR HR20000826A patent/HRP20000826A2/hr not_active Application Discontinuation
-
2003
- 2003-09-25 US US10/670,628 patent/US20040038288A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| NZ507982A (en) | 2004-01-30 |
| BR9910858A (pt) | 2001-03-06 |
| IL139595A0 (en) | 2002-02-10 |
| NO20006091D0 (no) | 2000-11-30 |
| PL344349A1 (en) | 2001-11-05 |
| EP1084235A1 (en) | 2001-03-21 |
| EA200001254A1 (ru) | 2001-06-25 |
| CA2330171A1 (en) | 1999-12-09 |
| HUP0102014A2 (hu) | 2001-10-28 |
| EP1084235A4 (en) | 2002-03-27 |
| JP2002517191A (ja) | 2002-06-18 |
| CO5070672A1 (es) | 2001-08-28 |
| ID27282A (id) | 2001-03-22 |
| HUP0102014A3 (en) | 2003-09-29 |
| CN1303428A (zh) | 2001-07-11 |
| AR020082A1 (es) | 2002-04-10 |
| WO1999063070A1 (en) | 1999-12-09 |
| DZ2803A1 (fr) | 2003-12-01 |
| ZA200006647B (en) | 2001-11-15 |
| HRP20000826A2 (en) | 2001-10-31 |
| PE20000561A1 (es) | 2000-07-22 |
| SK17502000A3 (sk) | 2001-09-11 |
| US20040038288A1 (en) | 2004-02-26 |
| KR20010043941A (ko) | 2001-05-25 |
| AU4409399A (en) | 1999-12-20 |
| SV1999000067A (es) | 2000-07-06 |
| TR200003552T2 (tr) | 2001-05-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0733109T3 (da) | BMP-12, BMP-13 og seneinducerende præparater dermed | |
| TR199801390T2 (xx) | Tromboz tedavisinde kullan�lacak p�ht�la�may� �nleyici maddeler | |
| DE60042137D1 (de) | Rekombinante alpha-l-iduronidase und behandlung von durch diese hervorgerufene mangelerkrankungen | |
| DE60233955D1 (de) | Spezifische bindungsmittel von human angiopoietin-2 | |
| DE60045034D1 (de) | Überstände von mesenchymstammzellen zur vorbeugung und behandlung von immunantworten in transplantationen | |
| ATE279181T1 (de) | Verwendung von 5ht-6 antagonisten zur behandlung adhd | |
| SE8902532D0 (sv) | Bestaemning av plasmaproteiner | |
| ATE275411T1 (de) | Verwendung von phyllanthus zur behandlung von chronisch entzündlichen und fibrotischen prozessen | |
| DE69932845D1 (de) | Methoden zur quantifizierung von hla-dr und cd11b | |
| PT948604E (pt) | Produtos e metodos relacionados com pyk2 | |
| DE69838509D1 (de) | Verwendung von rekombinanten menschlichen uteroglobin zur behandlung von fibrotischen krankheitszuständen | |
| DE69033511D1 (de) | Verfahren zum Nachweis von Knochen- und anderen Bindegewebeerkrankungen in Menschen und Tieren | |
| NO20006091L (no) | Humant protein C-polypeptid | |
| ATE313561T1 (de) | Vgf polypeptide und verfahren zur behandlung von vgf-erkrankungen | |
| DE60108076D1 (de) | Protein c derivate | |
| DE69932922D1 (de) | Verwendung von alkansäuren-enthaltenden zusammensetzungen zur behandlung von nagelpilz-erkrankungen | |
| WO1999058098A8 (en) | HUMAN ANTITHROMBIN IIIs AND METHODS RELATED THERETO | |
| EA200401390A1 (ru) | N-ацетилглюкозамин-6-фосфатдеацетилаза человека, взаимодействующая с каспазой-8, и способы ее применения | |
| DE60118769D1 (de) | Verwendung von langem pentraxin ptx3 zur behanlung von durch geänderte aktivität des fgf-2 wachstumsfaktors hervorgerufene krankheiten | |
| DE60144493D1 (de) | Verfahren zur bestimmung und behandlung von tuberöse-sklerose komplex assoziierten erkrankungen | |
| DE69734890D1 (de) | Rdgb-proteine | |
| WO2001036462A3 (en) | Protein c derivatives | |
| ES2070134T3 (es) | Inhibidores de lisil oxidasa. | |
| ATE269356T1 (de) | Mutierte gewebefaktor-inhibitor (tfpi), dna sequenz davon und verwendung zur erkennung von thrombotischen erkrankungen | |
| EA200100385A1 (ru) | Композиция и способ лечения нарушения гемостаза у субъекта (варианты) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |